Please login to the form below

Not currently logged in
Email:
Password:

Japan

This page shows the latest Japan news and features for those working in and with pharma, biotech and healthcare.

FDA approves Alexion’s Ultomiris for generalised myasthenia gravis

FDA approves Alexion’s Ultomiris for generalised myasthenia gravis

Multiple regulatory authorities are reviewing submissions for Ultomiris for the treatment of gMG, including those in the European Union (EU) and Japan.

Latest news

More from news
Approximately 51 fully matching, plus 931 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 113 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 42 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...